Two New Studies Highlight the Broad Utility of AACR Project GENIE Data
When creating anything new, one must ask the question, “will others use it?” A driving force behind the creation...
Category: AACR
When creating anything new, one must ask the question, “will others use it?” A driving force behind the creation...
Several options are available for the treatment of breast cancer, including local therapies such as surgery and radiation therapy,...
A new fellowship program is giving 20 early-career researchers a window into oncology drug development and the regulatory review...
As we enter the winter holiday season, it’s time for the latest edition of Editors’ Picks, our monthly staple...
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease with a grim prognosis. While early-stage PDAC may be removed by...
With coronavirus infections on the rise, we all feel the strain of the pandemic. The stress has deepened for those who are caring for people who are...
Breast cancer is the most common cancer among women in the United States and worldwide, with an estimated 2.1 million women diagnosed each year....
In June 2020, the American Association for Cancer Research (AACR) hosted the second class of Global Scholar-In-Training Awardees (GSITA) during...
The screen goes blue, that unmistakable tune starts playing, and the voice of Johnny Gilbert announces, “This. Is. Jeopardy!” We meet the contestants. We hear...
In 2019, Michael D. Story, PhD, vice chair of the Department of Radiation Oncology and chief of the Division of Molecular Radiation Biology at UT Southwestern Medical Center, was one of...